Skip to content

Clinical trials

Completed Liver Diseases trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Diseases Status: Completed Country / region: South Korea Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20144
20153
20161
20171
20183
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chuncheon Sacred Heart Hospital2
Samsung Medical Center2
Yonsei University2
Blueprint Medicines Corporation1
Chong Kun Dang Pharmaceutical1
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company1
Dong-A ST Co., Ltd.1
Gilead Sciences1
Imunon1
Seoul National University Bundang Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Diseases14
Carcinoma, Hepatocellular4
Diabetes Mellitus, Type 22
Digestive System Diseases2
Hepatitis B, Chronic2
Liver Neoplasms2
Non-alcoholic Fatty Liver Disease2
Adenocarcinoma1
Carcinoma1
DNA Virus Infections1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.